Allergic Bronchopulmonary Aspergillosis
📧 Sign up to get email alerts when something new happens for Allergic Bronchopulmonary Aspergillosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: Real-World Effectiveness of Benralizumab in Allergic Bronchopulmonary Aspergillosis
Clinical trial evaluating real-world effectiveness of benralizumab for allergic bronchopulmonary aspergillosis and severe asthma; currently …
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: A Cohort Study of the Efficacy and Safety of Biologics in Patients With ABPA
This entry notes ongoing recruitment for a cohort study evaluating the efficacy and safety of biologic therapies in patients with allergic b…
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: Oral Itraconazole Versus Combination of Systemic Glucorticoids and Oral Itraconazole in CPA-ABPA Overlap Syndrome [NA]
This clinical trial is evaluating oral itraconazole alone versus itraconazole with systemic glucocorticoids in patients with Chronic Pulmona…
-
CLINICAL_TRIALS research · 2026-03-25Clinical Trial Update: Immune Status and Disease Control of Inflammatory Airway Diseases
This clinical trial update describes a study evaluating immune status and disease control in inflammatory airway diseases, including COPD, a…
-
CLINICAL_TRIALS research · 2026-01-23Clinical Trial Update: A Study of the Efficacy and Safety of Bronchoscopic Airway Clearance and Amphotericin B Spraying in Patients With ABPA
A clinical trial is evaluating the efficacy and safety of bronchoscopic airway clearance with Amphotericin B spraying in patients with aller…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-01-02Clinical Trial Update: Effects of Environmental Fungal Exposure on Bronchial Asthma, ABPA and Bronchiectasis
A clinical trial is investigating the impact of environmental fungal exposure on asthma, allergic bronchopulmonary aspergillosis (ABPA), and…
-
CLINICAL_TRIALS research · 2025-07-04Clinical Trial Update: Pathogenesis and Inflammatory Phenotype of Allergic Bronchopulmonary Aspergillosis
A recruiting clinical study led by Qianfoshan Hospital aims to investigate the pathogenesis and inflammatory phenotype of Allergic Bronchopu…
-
CLINICAL_TRIALS research · 2025-05-22Clinical Trial Update: iMagIng pulmonaRy Aspergillosis Using Gallium-68-dEferoxamine [Phase 2]
Phase 2 clinical trial evaluating Gallium-68-deferoxamine for imaging in pulmonary aspergillosis, including chronic pulmonary aspergillosis …
-
CLINICAL_TRIALS research · 2025-02-28Clinical Trial Update: Deflazacort Vs. Prednisolone in Acute-stage ABPA [Phase 2, Phase 3]
Clinical trial comparing deflazacort to prednisolone in acute-stage allergic bronchopulmonary aspergillosis, with Phase 2 and Phase 3 studie…
-
CLINICAL_TRIALS research · 2025-02-28Clinical Trial Update: A Randomized Trial of Prednisolone, Itraconazole, or Their Combination in Allergic Bronchopulmonary Aspergillosis [Phase 3]
Phase 3 randomized trial evaluating prednisolone, itraconazole, or their combination for Allergic Bronchopulmonary Aspergillosis; currently …
-
CLINICAL_TRIALS research · 2024-10-16Clinical Trial Update: Multicenter Registration Study on Allergic Bronchopulmonary Aspergillosis
This entry reports a multicenter registration trial for allergic bronchopulmonary aspergillosis led by Peking University Third Hospital, cur…
-
CLINICAL_TRIALS research · 2024-07-18Clinical Trial Update: Immune Profiles in CF Fungal Infection
A completed clinical trial update examining immune profiles in cystic fibrosis patients with fungal infections, including allergic bronchopu…
-
CLINICAL_TRIALS research · 2018-08-23Clinical Trial Update: A Study Evaluating Vitamin D in Allergic Bronchopulmonary Aspergillosis Complicating Asthma [Phase 2, Phase 3]
A Phase 2/Phase 3 trial evaluating vitamin D for allergic bronchopulmonary aspergillosis complicating asthma has completed.
-
CLINICAL_TRIALS research · 2017-08-30Clinical Trial Update: Role of Thymus-And Activation-Regulated Chemokine (TARC) In Diagnosis Of Allergic Bronchopulmonary Aspergillosis
An update on a clinical study evaluating thymus and activation-regulated chemokine (TARC) as a diagnostic biomarker for allergic bronchopulm…
-
CLINICAL_TRIALS research · 2016-02-15Clinical Trial Update: Mechanisms of Immune Tolerance and Inflammation in Patients With Cystic Fibrosis With ABPA
This clinical trial update summarizes a mechanistic study in cystic fibrosis patients with allergic bronchopulmonary aspergillosis (ABPA) th…